Dietary magnesium restriction reduces amygdala–hypothalamic GluN1 receptor complex levels in mice

Brain Structure and Function

Volumn 220, Issue 4, 2015, Pages 2209-2221

  Ghafari, Maryam ^a   Whittle, Nigel ^b   Miklósi, András G ^a   Kotlowsky, Caroline ^a   Schmuckermair, Claudia ^b   Berger, Johannes ^c   Bennett, Keiryn L ^d   Singewald, Nicolas ^b   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Medical University of Vienna   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Amygdala; Depression; Dietary magnesium restriction; Forced swim test; Hypothalamus; NMDA; Receptor complexes

Indexed keywords

AMPA RECEPTOR; GLUN1 RECEPTOR; GLUN2A RECEPTOR; GLUN2B RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PAROXETINE; RECEPTOR SUBUNIT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; GPRIN1 PROTEIN, MOUSE; MAGNESIUM; NERVE PROTEIN; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; FORCED SWIM TEST; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAGNESIUM RESTRICTION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; WESTERN BLOTTING; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; COMPLICATION; DIET; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MAGNESIUM DEFICIENCY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MUS;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; DEPRESSION; DIET; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PAROXETINE; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN UPTAKE INHIBITORS;

EID: 84933179964     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-014-0779-8     Document Type: Article

References (55)

1. Akashi K, Kakizaki T, Kamiya H, Fukaya M, Yamasaki M, Abe M, Natsume R, Watanabe M, Sakimura K (2009) NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J Neurosci 29(35):10869–10882. doi:10.1523/JNEUROSCI.5531-08.2009
2. Augusto E, Matos M, Sevigny J, El-Tayeb A, Bynoe MS, Muller CE, Cunha RA, Chen JF (2013) Ecto-5′-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. J Neurosci 33(28):11390–11399. doi:10.1523/JNEUROSCI.5817-12.2013
3. Bardgett ME, Schultheis PJ, McGill DL, Richmond RE, Wagge JR (2005) Magnesium deficiency impairs fear conditioning in mice. Brain Res 1038(1):100–106
4. 2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor. J Biol Chem 272(52):32727–32730
5. Bayer KU, De Koninck P, Leonard AS, Hell JW, Schulman H (2001) Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411(6839):801–805. doi:10.1038/35081080
6. Bayer KU, LeBel E, McDonald GL, O’Leary H, Schulman H, De Koninck P (2006) Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. J Neurosci 26(4):1164–1174. doi:10.1523/JNEUROSCI.3116-05.2006
7. Bennett KL, Funk M, Tschernutter M, Breitwieser FP, Planyavsky M, Ubaida Mohien C, Muller A, Trajanoski Z, Colinge J, Superti-Furga G, Schmidt-Erfurth U (2011) Proteomic analysis of human cataract aqueous humour: comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ(R)-labelled specimens. J Proteomics 74(2):151–166
8. Boyce-Rustay JM, Holmes A (2006) Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 31(11):2405–2414. doi:10.1038/sj.npp.1301039
9. Chen P, Li X, Sun Y, Liu Z, Cao R, He Q, Wang M, Xiong J, Xie J, Wang X, Liang S (2006) Proteomic analysis of rat hippocampal plasma membrane: characterization of potential neuronal-specific plasma membrane proteins. J Neurochem 98(4):1126–1140
10. Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hortnagl H, Riva MA, Sprengel R, Gass P (2008) AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 22(9):3129–3134. doi:10.1096/fj.08-106450
11. Cooper JR, Bloom FE, Roth RH (1996) The biochemical basis of neuropharmacology. Oxford, New York, pp 518
12. Cowan JA (2002) Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals 15(3):225–235
13. Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS (2009) Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Res 1265:186–195. doi:10.1016/j.brainres.2009.02.002
14. Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169(1):1–10. pii:0014-2999(89)90811-X
15. Eby GA, Eby KL (2006) Rapid recovery from major depression using magnesium treatment. Med Hypotheses 67(2):362–370
16. Finkel MS, Laghrissi-Thode F, Pollock BG, Rong J (1996) Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 32(4):653–658
17. Garfinkel L, Garfinkel D (1985) Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 4(2–3):60–72
18. Ghafari M, Patil SS, Hoger H, Pollak A, Lubec G (2011) NMDA-complexes linked to spatial memory performance in the Barnes maze in CD1 mice. Behav Brain Res 221(1):142–148
19. Ghafari M, Falsafi SK, Hoeger H, Lubec G (2012a) Hippocampal levels of GluR1 and GluR2 complexes are modulated by training in the Multiple T-maze in C57BL/6J mice. Brain Struct Funct 217(2):353–362
20. Ghafari M, Hoger H, Keihan Falsafi S, Russo-Schlaff N, Pollak A, Lubec G (2012b) Mass spectrometrical identification of hippocampal NMDA receptor subunits NR1, NR2A-D and five novel phosphorylation sites on NR2A and NR2B. J Proteome Res 11(3):1891–1896. doi:10.1021/pr201099u
21. Gould TD, O’Donnell KC, Dow ER, Du J, Chen G, Manji HK (2008) Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54(3):577–587. doi:10.1016/j.neuropharm.2007.11.002
22. Hackbarth H, Kuppers N, Bohnet W (2000) Euthanasia of rats with carbon dioxide––animal welfare aspects. Lab Anim 34(1):91–96
23. Haddad JJ (2005) N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol 77(4):252–282
24. Kang SU, Fuchs K, Sieghart W, Lubec G (2008) Gel-based mass spectrometric analysis of recombinant GABA(A) receptor subunits representing strongly hydrophobic transmembrane proteins. J Proteome Res 7(8):3498–3506
25. Kantak KM (1988) Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci 102(2):304–311
26. Kobayashi K, Haneda E, Higuchi M, Suhara T, Suzuki H (2012) Chronic fluoxetine selectively upregulates dopamine D(1)-like receptors in the hippocampus. Neuropsychopharmacology 37(6):1500–1508. doi:10.1038/npp.2011.335
27. Koenig JH, Ikeda K (1996) Synaptic vesicles have two distinct recycling pathways. J Cell Biol 135(3):797–808
28. Kreis P, Barnier JV (2009) PAK signalling in neuronal physiology. Cell Signal 21(3):384–393. doi:10.1016/j.cellsig.2008.11.001
29. Layer RT, Popik P, Olds T, Skolnick P (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52(3):621–627 (pii:0091-3057(95)00155-P)
30. Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, Hell JW (2002) Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-d-aspartate receptors by calcium/calmodulin and alpha-actinin. J Biol Chem 277(50):48441–48448. doi:10.1074/jbc.M205164200
31. Maj J, Rogoz Z, Skuza G, Sowinska H (1992) The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm 44(4):337–346
32. Merrill MA, Chen Y, Strack S, Hell JW (2005) Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol Sci 26(12):645–653. doi:10.1016/j.tips.2005.10.003
33. Murck H (2002) Magnesium and affective disorders. Nutritional Neurosci 5(6):375–389
34. Murck H (2013) Ketamine, magnesium and major depression––from pharmacology to pathophysiology and back. J Psychiatr Res 47(7):955–965. doi:10.1016/j.jpsychires.2013.02.015
35. Muroyama A, Inaka M, Matsushima H, Sugino H, Marunaka Y, Mitsumoto Y (2009) Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice. Neurosci Res 63(1):72–75
36. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, Mann M (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4(12):2010–2021
37. Plaznik A, Palejko W, Nazar M, Jessa M (1994) Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol 4(4):503–512
38. Przegalinski E, Tatarczynska E, Deren-Wesolek A, Chojnacka-Wojcik E (1997) Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology 36(1):31–37. pii:S0028390896001578
39. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95(24):14476–14481
40. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED (2011) Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 31(16):6008–6018. doi:10.1523/JNEUROSCI.5836
41. Saatman KE, Bareyre FM, Grady MS, McIntosh TK (2001) Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. J Neuropathol Exp Neurol 60(2):183–194
42. Sartori SB, Whittle N, Hetzenauer A, Singewald N (2012) Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology 62(1):304–312
43. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H (2004) Magnesium-deficient diet alters depression- and anxiety-related behavior in mice––influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47(8):1189–1197
44. Sowa-Kucma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W, Poleszak E, Pilc A, Nowak G (2013) Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord 151(3):924–931. doi:10.1016/j.jad.2013.08.009
45. Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS (2008) Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zh Vyssh Nerv Deiat Im I P Pavlova 58(4):476–485
46. Tan SE, Wenthold RJ, Soderling TR (1994) Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J Neurosci 14(3 Pt 1):1123–1129
47. Tang TT, Badger JD 2nd, Roche PA, Roche KW (2010) Novel approach to probe subunit-specific contributions to N-methyl-d-aspartate (NMDA) receptor trafficking reveals a dominant role for NR2B in receptor recycling. J Biol Chem 285(27):20975–20981. doi:10.1074/jbc.M110.102210
48. Trifilieff P, Rives ML, Urizar E, Piskorowski RA, Vishwasrao HD, Castrillon J, Schmauss C, Slattman M, Gullberg M, Javitch JA (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques 51(2):111–118. doi:10.2144/000113719
49. Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185(1):1–10. doi:10.1016/0014-2999(90)90204-J
50. Weinhofer I, Forss-Petter S, Zigman M, Berger J (2002) Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Hum Mol Genet 11(22):2701–2708
51. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS (1996) Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16(6):1982–1989
52. Whittle N, Li L, Chen WQ, Yang JW, Sartori SB, Lubec G, Singewald N (2011) Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids 40(4):1231–1248
53. Wlaz P, Kasperek R, Wlaz A, Szumilo M, Wrobel A, Nowak G, Poleszak E (2011) NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol Rep 63(6):1526–1532
54. 2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in non-N-methyl-d-aspartate glutamate receptors. Proc Natl Acad Sci USA 92(5):1376–1380
55. Zukin RS, Bennett MV (1995) Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18(7):306–313. doi:10.1016/0166-2236(95)93920-S